Nanotech device aims to save jawbone after tooth loss
NCT ID NCT07371130
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a low-intensity nanotechnology device combined with a bone graft and membrane to preserve the jawbone after tooth extraction. Twenty adults needing tooth removal and later dental implants will participate. The goal is to reduce bone loss and improve healing, making implant placement easier.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- xenogeneic bone graft with hyaluronic acid and dermal matrix membrane
- What this could lead to
- If successful, this could improve bone preservation after tooth extraction, making future dental implants more stable and successful.
- What could go wrong
- This is a very small early trial with only 20 participants, so results may not apply widely. The procedure is surgical and carries risks like infection or poor healing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults in good general health * Indication for tooth extraction in sites planned for delayed implant placement * Inability to place immediate post-extraction implants due to insufficient residual bone to ensure primary stability * Extraction sockets presenting absence of the buccal (vestibular) bone wall * Signed informed consent Exclusion Criteria: * Systemic conditions affecting bone healing * Uncontrolled periodontal disease * Smoking \>10 cigarettes/day * Pregnancy or lactation * Use of medications interfering with bone metabolism
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Tooth avulsion are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.